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Abstract 
In recent years focused research aimed at finding new specific and sensitive biomarkers for detection, 
classification and, monitoring of human cancers has been ongoing. MicroRNAs (miRNAs) are small, 
19-24 nucleotides, noncoding RNAs that are stably expressed in body fluids such as blood. These 
circulating RNAs have shown great promise as biomarkers, because the unique expression patterns 
strongly correlate with certain human diseases, including various types of cancer. These miRNAs act 
mainly through down regulation of specific target mRNAs in the cytosol and have been shown to be 
key regulatory players in several important cellular processes. In this project sequence data of 
circulating small RNAs, 18-30 nucleotides, from blood serum were analyzed and compared to 
sequence data from blood cells and two blood cancer cell lines. The results showed that a surprisingly 
large part of the small RNAs in human serum did not match the human genome. Moreover, the results 
indicate the existence of several novel miRNAs in the human genome. When comparing the most 
frequent RNA molecules, differences between the compared samples were striking and several well 
described miRNAs showed up amongst these differently expressed RNAs. Despite huge progress in 
recent years, there are still more research needed in this field; most likely several novel miRNAs are 
still to be found in the human genome and, the involvement of certain miRNAs as key regulators in 
important cellular processes are to be expected. In some years to come, probably some miRNAs will 
prove to be reliable biomarkers for some specific trait. 
Master’s degree project in Molecular Biology, Mikael Lindberg  
2 
 
Introduction 
The field of small regulatory RNA molecules is a relatively young discipline. Twenty years ago, in 
1993, Victor Ambros and Gary Ruvkun published two papers describing the regulatory roles of small 
RNA molecules involved in the developmental control of the nematode Caenorhabditis elegans (Lee 
et al. 1993, and Wightman et al. 1993). They called these molecules microRNAs (miRNAs) and 
suggested that they are able to control and regulate the expression of target genes by interacting with 
the 3'UTR (untranslated region) of their target mRNAs. In 2006, Andrew Fire and Craig Mello 
received the Nobel Prize in physiology and medicine for their discovery of the process named RNA 
interference (RNAi) (Fire et al. 1998, and Martin-Muller et al. 2010). In short, it describes how 
double-stranded RNA triggers suppression of gene activity in a homology-dependent manner. 
Biochemical dissection of the mechanisms behind miRNA and RNAi revealed that these were two 
closely connected cellular processes. In 2001, a breakthrough came revealing a large number of 
microRNAs (Lau et al. 2001; Lagos-Quintana et al. 2001; Lee et al. 2001). Since then, a lot of new 
miRNAs have been reported, and at present there are 2,237 unique mature human miRNAs in the 
Sanger Centre miRBase Database (release 19), the central repository of miRNA sequences (miRBase 
2012, and Griffiths-Jones et al. 2006). 
The biogenesis and nomenclature of microRNAs  
The miRNAs can be positioned in introns or in exons within genes and they can also be positioned 
independently of any protein coding gene with its own promoter. miRNA-like small RNAs have even 
been found within tRNA genes (Pederson et al. 2010, and Haussecker et al. 2010), snoRNAs (Ender et 
al. 2008) and vault RNAs (Persson et al. 2009). Some miRNA are organized into clusters and 
transcribed as a long polycistronic precursor. Most known miRNA to date are transcribed by RNA 
polymerase II (Lee et al 2004). The transcript is called pri-miRNA, can vary in size and contains the 
characteristics of RNA polymerase II transcripts e.g. a poly-A tale and a 5’cap. The pri-miRNA is 
folded back to create a hairpin stem-loop structure. These precursors are spliced in the nucleus by an 
RNase III enzyme called Drosha to create a ~70 nt pre-miRNA. Drosha forms a small 
“microprocessor” complex that recognizes the double stranded miRNA with the help of several 
proteins, among others a protein called DGCR8 (also known as Pasha) (Davis et al. 2010). The stem-
loop structure is kept intact whereas the 5' and 3' ends are trimmed by Drosha (Davis et al. 2010). The 
pre-miRNA is transported to the cytoplasm by exportin-5, a process that is guanosine triphosphate 
(GTP)-dependent (Martin-Muller et al. 2010). 
In the cytoplasm, a second RNase III enzyme named Dicer cuts the pre-miRNA to create the ~22 
nucleotide (nt) mature miRNA and its complementary strand, the star sequence (*), disrupting the 
stem-loop. The mature miRNAs are single-stranded RNA molecules that act as posttranscriptional 
regulators of gene expression. The nomenclature of miRNAs states that a mature miRNA is written 
miR-… and the complementary star sequence is written miR-…*, where the dots are the specific 
number of the miRNA. Sometimes only one molecule is active and sometimes both have targets which 
they act on. The two molecules can also be called 3p and 5p, distinguishing them by the means of 
from which end of the pre-miRNA stem-loop they originate from, the 3' or 5' end (Ambros et al. 
2003). There are some microRNAs, like the let-family, that do not follow the common nomenclature 
because the names of these microRNAs were already established when the nomenclature was 
introduced.   
The miRNAs are identified and incorporated in the RNA interference silencing complex (RISC). The 
RISC consists of several different proteins which differ in different species. The most important RISC 
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component is the argonaute protein which binds the miRNA double strand. In humans there are eight 
different argonaute proteins (Mallory et al. 2010). They seem to have various roles in the silencing 
machinery. One of the miRNAs (the miR or miR*) is chosen and a complementary target mRNA is 
identified. Which mRNA to target is decided by the seed sequence of the miRNA. The seed sequence 
consists of the 2-8 nt from the 5' end (Martin-Muller et al. 2010). Depending on the seed sequence 
miRNAs are divided into families which are predicted to have the same targets.  
Following identification of the target mRNA one of several things can happen. If the complementarity 
of the seed sequence and the target mRNA is perfect, the mRNA is cut by the argonaute protein 
(Ago2) and the RISC can bind another mRNA. If the seed sequence is not of perfect match the mRNA 
is not cut but instead the RISC complex hinders ribosomes from binding and translation to begin (Lim 
et al. 2005). These two actions are the most common actions and are both examples of negative 
regulation of mRNAs. Which action a specific miRNA will have on its target mRNA is not known. 
The RISC with the miRNA/mRNA complex is believed to be located into processing bodies (P-
bodies). P-bodies are cellular structures in the cytosol enriched in mRNA-degradation enzymes 
(Martin-Muller et al. 2010). As mentioned above most miRNAs act as negative regulators of mRNAs 
but there have also been reports of positive regulating miRNAs. For example, miR-10a has been 
shown to bind to the 5'UTR of mRNAs encoding ribosomal proteins and enhancing their translation 
(Anderson et al. 2008). 
One miRNA can have several different target mRNAs and a mRNA can be targeted by several 
different miRNAs (Lim et al. 2005). Predictions on the human mRNA estimate that more than 60% 
are potential targets for miRNA regulation (Freidman et al. 2009). These estimates are made on target 
sites in the 3'UTR of the mRNAs because most miRNAs has been reported to target this region. Some 
miRNAs can also target inside the coding sequence of their target mRNAs and as mentioned earlier, 
miR-10a binds its targets in the 5'UTR (Anderson et al. 2008). With this in mind the amount of 
mRNAs under the regulatory control of miRNA might even be higher than 60%. 
MicroRNAs circulating in the blood 
MiRNA was first described circulating in the human blood serum and plasma in 2008 (Chen et al. 
2008, Chim et al. 2008, Lawrie et al. 2008, and Michell et al. 2008). In these studies it was shown that 
miRNAs were remarkably stable and in some way protected from endogenous RNase activity in the 
blood. Since then, several papers have been published in the attempt to describe these circulating 
miRNAs. The miRNA profiles have been shown to differ extensively between healthy individuals 
(with gender, age, pregnancy etc.) and between different medical conditions, e.g. different types of 
cancers and, diabetes (Zen and Zhang 2010). Human microRNA-genes have also been shown to 
frequently being located at fragile sites and genomic regions involved in various cancers (Calin et al. 
2004).  
The fact that circulating miRNAs have shown to be highly stable in plasma and are relatively easy to 
measure with great sensitivity, combined with the strong association with disease states, have made 
circulating miRNAs strong candidates as a new class of biomarkers. The underlying reason for the 
high stability of miRNAs in plasma is not known, but it has been suggested that they are protected by 
encapsulations into lipid vesicles such as exosomes. There are several different types of lipid vesicles 
circulating in the blood and some are called microvesicles (MVs). Recently, MVs have been shown to 
shuttle specific miRNAs promoting proliferation and mobility between macrophages and breast cancer 
tumors (Yang et al. 2011). However, in a recent paper evidence is presented showing that a majority 
of circulating miRNAs are associated with the Ago2 protein in the blood and only a minority are 
associated to MVs and other lipid vesicles (Arroyo et al. 2011).  
Master’s degree project in Molecular Biology, Mikael Lindberg  
4 
 
The origin of the circulating miRNAs in the blood is not known; with some exceptions of miRNAs 
with a known tissue specific origin, e.g. miR-122, which is expressed by liver cells (Jopling 2012). In 
a recent study it was shown that out of 79 previously reported solid tumor circulating miRNAs, 58 % 
were highly expressed in one or more blood cell type (Pritchard et al. 2012). Consequently they argue 
that the origin of these miRNA could be from blood cells and not the tumors. To this can be added that 
the miRNA population in blood cells has been shown to shift and reflect the presence of diseases that 
are not necessarily blood-borne diseases (Keller et al. 2011). The underlining cause of this change is 
not known but it could be as a response to changes in the environment caused by the disease, the 
authors of these findings argue.  
Experimental techniques, next generation sequencing 
There are three methods commonly used to detect miRNAs: next generation sequencing, microarrays, 
and reverse transcription quantitative polymerase chain reaction (RT qPCR). Next generation 
sequencing refers to the DNA sequencing technologies developed since 2005 that have reduced the 
cost and increased the data throughput (Nelson et al. 2011). Next generation sequencing is also 
referred to as high-throughput sequencing or deep sequencing. 
With the introduction of next generation sequencing the science community realized that most 
miRNAs exist in various lengths. A specific miRNA can vary in length due to some variation in 
processing by Drosha and Dicer and/or can exist with several different additions both in the 3' and 5' 
ends. Nucleotide substitutions have also been reported. First variation in the 3' end was coined 
isomiRs (Morin et al. 2008). Later this term has been broadened to also include variations in the 5' 
ends of miRNAs. The variations in the 5' end changes the seed sequence of the miRNA and has 
thereby been controversial because the predicted targets are also changed. Often one form is the most 
common one and then this form is the one that is described in miRBase. In a recent paper, Lee and 
coworkers presented a comprehensive study over isomiRs from human and mouse samples (Lee et al. 
2010). They argue that the heterogeneity amongst miRNAs are nonrandom and does not originate as a 
defect of the sequencing technique which was previously raised as a concern.  
The project 
In this project the initial plan was to investigate the miRNA profile in blood plasma from breast cancer 
patients that had established metastases. More specifically, the aim was to identify potential miRNA 
biomarkers that could indicate in what tissue an aggressive breast cancer would metastasize. The 
technique to be used to map the miRNA was next generation sequencing and the patients were to be 
matched to healthy controls. However, due to complications in the laboratory, no final sequence data 
was obtained even if all the experimental steps (RNA isolation, quality control, sample preparation for 
next generation sequencing and the actual sequencing) were performed by me in the lab. The final data 
analysis of sequence data were performed on fourteen datasets publically available in the Gene 
Expression Omnibus (GEO) database. The datasets originate from two papers published in 2010 and 
2012 (Vaz et al. 2010 and Zhang et al. 2012). The RNA extraction and library creation protocols used 
in both these experiments were highly similar to the procedure performed and described here. In these 
studies, ten sequencing datasets were generated from pooled serum samples from healthy Chinese 
individuals, while two datasets originate from blood cells from two healthy Indian individuals, and 
two datasets originate from two different cancer cell lines originating from blood cancer cells. 
Zhang et al. 2012 focused on foreign/non-human miRNAs, e.g. miR-168 from plant, circulating in the 
blood stream. They presented, through several experiments, the first evidence that exogenous plant 
miRNA, through food intake, can enter the blood stream, be taken up by various tissues and cells, and 
there regulate the expression of target genes in mammals. We found that a surprisingly large portion of 
Master’s degree project in Molecular Biology, Mikael Lindberg  
5 
 
the small RNA sequences in the ten serum libraries were non-human, e.g. not aligned to the human 
genome. This is in line with the findings of Zhang et al. 2012. Whereas Zhang et al. 2012 run their 
libraries against all known miRNAs in the miRBase we run their libraries against the entire human 
genome. Other small RNA molecules than the known miRNAs will be identified when running against 
the entire human genome. In this way the sequence data that was obtained will differ and giving some 
scientific relevance to our data analysis.  
The other paper, Vaz et al. 2010, is a comparison of the miRNA profile of normal white blood cells 
(leukocytes) and two different cancer cell lines both originating from blood cells. In this study the 
authors show that there is a difference in miRNA expression patterns, and they also present 370 novel 
miRNA. They ran their libraries against the human genome in a similar fashion as we did, but at the 
time of their analysis there were not as many known human miRNAs in the miRBase as of today. Our 
analysis of the Vaz et al. 2010 data confirmed their findings. The potential blood cell origin of 
circulating miRNAs is being debated in the scientific community, and therefore a comparison between 
the small RNA profiles of the normal white blood cells and the small RNA profiles from the serum 
libraries, is of interest. This was the reason for choosing the Vaz et al. 2010 datasets. 
The two papers and the fourteen datasets are presented and described in more depth in the materials 
and methods. There, questions are presented on comparison between the libraries and the answers to 
the questions are later presented in the results. The questions and results that came out of the data 
analysis are not directly related to the questions on breast cancer metastases, as of the questions in the 
original plan. Instead, the results highlight some interesting things about circulating miRNA in a more 
broad sense, like gender and age differences, along with the interesting comparison to the original 
papers. 
 
Materials and Methods 
This section contains a description of techniques, procedures and protocols used according to the 
initial project plan. Even though, no final sequence data were obtained in this study, the preparations 
are nevertheless, as mentioned earlier, highly similar to the preparations made in the two papers that 
generated the datasets used in this report. 
When working with RNA, it is of outmost importance to take precautions to avoid exposure to RNase 
enzymes. Compared to DNases, RNases are much more stable. There are RNases on the skin of 
humans so gloves should be worn at all times when handling samples, tubes and equipment used for 
RNA preparation and analysis (Bustin 2004). Special RNase free water was used at all times and the 
laboratory work was done on lab benches and in rooms dedicated for working only with RNA. 
Blood sample collection and preparations 
All blood material that was used was blood from the author himself collected at two different dates, 
2011-09-30 and 2011-10-28 (4 tubes with 6 ml, in total 24 ml, at both occasions). The blood was first 
collected in EDTA tubes (K2E 10.8mg Plus Blood Collection Tubes manufactured by BD Vacutainer) 
and then incubated at room temperature for 30 minutes. EDTA is an anticoagulant that prevents blood 
from clotting. Following the incubation the tubes were centrifuged at 2,000 x g for 10 minutes at room 
temperature. After centrifugation the blood is separated in three different layers. The lowest layer 
consists of red blood cells and on top of this layer are the white blood cells. The upper layer is the 
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plasma which consists of the cell free blood and is approximately 55% of the volume. The plasma was 
taken from the tube and put in 1.5 ml microcentrifuge tubes in aliquots of 300 µl. These tubes were 
stored in a -70°C freezer. Blood plasma is easily confused with blood serum which is the cell free fluid 
that is left when blood has been allowed to clot. When collecting blood with the aim of recovering 
serum, other tubes not containing any anticoagulant are used. One could roughly say that serum is 
plasma without fibrinogen and other clotting factors because these are pelleted along with the cells 
after clotting and centrifugation. It has been shown that miRNA profiles in plasma and serum, taken 
from the same individual, are very similar and in this field of research there has not been any decision 
whether to use serum or plasma as a standard.  
Instead of using EDTA tubes sometime Heparin coated tubes are used to collect plasma. Heparin is a 
naturally occurring polysaccharide found in the artery walls and is an anticoagulant just as EDTA 
(Kim et al. 2012). It has been shown that Heparin interferes with PCR reactions and other downstream 
applications, and therefore is not recommended when investigating miRNAs and similar molecules. 
Additional heparin is commonly given to patients who undergo transplantations heart surgery or have 
had a stroke or similar problems connected to blood clotting (Kim et al. 2012). Because of this the 
kind of medicine given to the patients and controls are of outermost importance when investigating 
miRNA. It has been shown that heparinized samples treated with heparinase, an enzyme degrading 
heparin, prior to RT-PCR increase detection of otherwise undetected miRNAs (Kim et al. 2012). 
Synthetic spiked-in RNA as controls 
Synthetic RNA spikes similar in size to miRNAs can be used as controls when investigating and 
comparing miRNA level in parallel samples. The spikes are added to all samples in an early step of the 
preparations. By knowing that the concentrations of spikes were the same in the early stage one can in 
the end analysis use this to normalize the sample data to each other. In this way the data can be 
compared in a more true sense. The normalization takes away differences in the data that is due to 
handling differences, i.e. unequal loss of material due to small pipetting errors, incomplete 
precipitations, pellet recoveries etc.  
To each plasma sample (of 300 µl) a spike pool was added containing synthetic RNAs spikes in the 
size of miRNAs. In total twelve spikes were used, see table 1. Ten of the spikes were 24 nt long and 
these were diluted in a series by a fifth (starting from 0.01 nM going down to 5.12*10
-9
 nM in the 
spike pool). Two of the spikes were in the same concentration, 0.005 nM, in the spike pool. These two 
were 19 nt in length and differed in sequence only in the eleventh nt, which was a G in one and an A 
in the other. In table 1 the synthetic RNAs are presented in name, sequence, length, concentration in 
the spike pool, and approximate amount of copies added to the plasma sample prior to RNA 
extraction. The way to estimate the amount of copies was to multiply the spike pool concentrations 
with the Avogadro constant (6.02*10
23
), the volume added (10 µl = 10*10
-6
 liter), and the abbreviation 
nano (10
-9
) in front of the molar sign. 
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Table 1. The sequence and length of 12 synthetic RNAs. The table also presents the concentrations of the spike 
pool and the approximate amount of copies added to the plasma samples prior to the RNA extraction. 
 
The spikes were phosphorylated in the 5'-end in a reaction with T4 Polynucleotide Kinase gene PNK 
(NEB, New England BioLabs). This was done to allow subsequent ligation of adapters on the spikes 
later on in the creation of libraries. The reaction setup were a phosphorylation step at 37°C for 30 
minutes, followed by an enzyme heat inactivation step at 60°C for 20 minutes according to the 
manufacturer’s instructions.  
Test runs were made on plasma containing different dilutions of the spike pool. The plasma samples 
used in these tests were from the collection described above and the RNA extraction and library 
creation followed the procedure described in the forthcoming text. The reason for running these tests 
were to practice and validate the program and to figure out what concentration of the spike pool to 
add. The spikes should be in concentrations that are detectable in all samples, but should not be a too 
big part of the overall reads in the sequence data.  
The spikes were ordered from a company called Integrated DNA Technology (IDT) (web site: 
http://eu.idtdna.com/site). The spikes were tested and validated prior to use with quantitative PCR 
(qPCR) to verify their detectability and stability in plasma. The qPCR method that was used is called 
miR-specific quantitative RT-PCR with DNA primers (Balclls et al. 2011). In short the method uses a 
poly(A) polymerase to extend the 3' end of the targets, followed by a cDNA synthesis with a reverse 
transcriptase and an anchored poly(T) primer. Then the qPCR reaction is run with SYBR-Green, a 
target specific forward primer and a reverse primer. In qPCR, the amplified DNA product is measured 
after each round of amplification with the use of the SYBR-Green molecule that fluoresces when 
binding to double stranded DNA (dsDNA). Since the amplification in theory is equal for different 
starting materials, the amount of end product is proportional to the starting material. Consequently, in 
theory one could calculate the starting amount of a specific amplified product and compare different 
amounts of different samples. None of the spike validation data has been included in the results of this 
report. 
Total RNA extraction and isolation 
In order to create libraries for sequencing, one must start by extracting and isolating the total RNA in 
the plasma samples. There are several techniques used to extract RNA from biological samples. There 
is not one specific method that has been proven to be much superior to the other. The technique used 
her is based on phase separation whit phenol and chloroform, followed by precipitation of the RNA 
with ethanol. TRIzol
®
 LS reagent provided by Invitrogen, which is designed for liquid solutions, was 
Name Sequence 5'-> 3' 
Length 
nt 
Spike Pool 
Conc. nM 
Approximate amount 
of copies added 
RNA spike 1 GCGGUCCAACGAAUAUCGA 19 0.005 30000000 
RNA spike 2 GCGGUCCAACAAAUAUCGA 19 0.005 30000000 
Control-11 GAUUAGCGGUUCCGGUAUGGGCAC 24 0.01 60000000 
Control-12 AUUCCUACGACGCGGCGUUCGUUG 24 0.002 12000000 
Control-13 CGGACGCAACGGACGAUAACAACC 24 0.0004 2400000 
Control-14 AUUCUGCGACGUGUUGCGCUCGGA 24 0.00008 480000 
Control-15 CAUACGGACGUUUACGCACGUUCA 24 0.000016 96000 
Control-16 CCGUGACGUGUACCGCCGCCUAUA 24 0.0000032 19200 
Control-17 CCGACGGUACUACAUAGACGACGU 24 0.00000064 3840 
Control-18 CUACGCACGACUUAGUCGUUCGAG 24 0.000000128 768 
Control-19 UCGGAUCGUUAUAGGUAUUGCGCA 24 2.56E-08 154 
Control-20 CGCAUCACGUCCGUUGCGUUAGAU 24 5.12E-09 31 
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the phenol reagent that was used. The following text describes the extraction and isolation protocol of 
total RNA.  
Each plasma sample tube contained 300 µl. To each tube 900 µl TRIzol LS reagent (3:1 volumes) was 
added and the samples were homogenized with a pipette. Then 10 µl of the spike pool were added to 
each tube and the tubes were incubated 10 minutes in room temperature for total disassociation of 
RNA-protein complexes. Thereafter 240 µl of absolute chloroform (99%) were added and the tubes 
were shaken vigorously 15 seconds and incubated 2-3 minutes at room temperature. The tubes were 
centrifuged at 12,000 x g for 15 min at 4°C. The samples separate into three phases: a transparent 
upper aqueous phase containing RNA, a white thin interphase containing DNA, and a red-pink lower 
phenol phase. The aqueous phase was carefully transferred to a fresh tube. Then 1 µl glycogen 
(20µg/µl) and 600 µl absolute ethanol (99%) was added to each tube. The tubes were inverted several 
times to mix, incubated 15 minutes at room temperature, and then centrifuged at 12,000 x g for 30 
minutes at 4°C. The supernatants were carefully removed and the pellets were washed with 1.2 ml 
75% ethanol by centrifugation at 12,000 x g for 10 minutes at 4°C. The supernatants were removed 
carefully and the pellets were air-dried 5-10 minutes in room temperature. Then the pellets were 
dissolved in 10 µl nuclease-free H2O and the samples were stored in -70°C for later use. 
A NanoDrop was used to measure the concentration and quality of the samples. NanoDrop is a 
photometrical technique that is widely used to measure concentrations of nucleic acids and proteins. A 
small volume (1 µl) of the sample is put on the NanoDrop and the absorbance at different wavelengths 
in the ultraviolet light spectrum is measured. The A260/A280 ratio should be 1.8-2 and the 
A260/A230 ratio should optimally be 2 or above for RNA. A lower A260/A280 ratio may be caused 
by contaminating DNA or protein. A lower A260/A230 ratio than 2 may be caused by traces of 
contaminating phenol, which could interfere with downstream experiments (Bustin 2004). 
Pre-sequencing preparation and cDNA library construction 
In order to run the sequencing on the samples, libraries needed to be constructed. The protocol used 
was a modification of the “Small RNA v1.5 Sample Preparation Guide” from Illumina. The procedure 
is described in detail in the following text and a schematic overview is presented in figure 1. 
  
Figure 1. Schematic illustrative overview of the preparations and construction of small RNA libraries for 
sequencing. The star on the 3'-adapter indicates a chemical modification that eliminates ligation on this end of 
the adapter.  
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When constructing libraries for sequencing, one can choose amongst several different approaches. 
Since the modern sequencing techniques read huge amounts of sequences, one can pool several 
libraries and still get good coverage of all sequences in each library. To be able to pool libraries and 
still be able to distinguish them, a unique barcode is incorporated which is sequenced along with the 
target sequences. This technique is referred to as multiplexing. We chose an approach where we used 
one 3'-adapter, the same for all, and different 5'-adapters with unique barcodes for each library. 
3' and 5' adapter ligations 
The first step in the creation of libraries is to ligate adapters on to the ends of all the isolated RNA 
molecules. The 3' and 5'-adapters are ligated in two separate reactions using two different T4 RNA 
Ligases. In the 3'-adapter ligation step the ligase used was T4 RNA Ligase 2 truncated (NEB, New 
England BioLabs). This enzyme specifically ligates the pre-adenylated 5' end of DNA or RNA to the 
3' hydroxyl-terminated end of a RNA molecule. The enzyme does not use ATP for ligation but 
requires pre-adenylated linkers. The 5'-adapter was ligated with T4 RNA Ligase 1 (NEB, New 
England BioLabs) which catalyzes the ligation of a 5' phosphoryl-terminated DNA or RNA donor to a 
3' hydroxyl-terminated DNA or RNA acceptor with the hydrolysis of ATP to AMP and PPi. 
The adapters used are presented in table 2. The first adapter in the table is the 3'-adapter provided by 
Illumina. This primer was used in all preparations and is a RNA molecule. The “APP” in the 5' end 
indicates that the adapter is pre-adenylated which is necessary in order for the ligation to work in the 
absence of ATP, improving the ligation efficiency avoiding self-ligation or circularization of the small 
RNAs when using truncated T4 RNA ligase. The “idT” in the 3' end indicates that the last nucleotide 
is modified, preventing ligations in this end and adapter-dimer formations. The next eight adapters are 
5'-adapters with barcodes in the 3' end. These adapters are built up by both RNA and DNA. The last 5 
nucleotides are RNA including the barcode, the barcode is highlighted in red and the two other RNA 
nucleotides are highlighted in green in figure 2. The rest of the adapter is DNA and is highlighted in 
blue. These eight adapters were designed by the group and ordered from a company called Eurofins 
MWG Operon (web site: www.eurofinsdna.com). The first four 5'-adapters (number 1-4) have two 
identical RNA nucleotides then the three letter barcode. The next four 5'-adapters (number 5-8) are 
two nucleotides longer and have the three letter barcode first then two identical RNA nucleotides. The 
reason for this difference was that 5'-adapters 1-4 was designed and ordered in an earlier stage. 
Concerns that the ligations efficiency could differ due to the different nucleotides in the 3' end lead to 
the design of 5'-adapters 5-8 where the last two nucleotides are the same for all adapters (A and U). 
Table 2. The 3' and 5'-adapters used in the preparation of libraries for sequencing. The barcodes in the 5'-
adapters are highlighted with red color, the non-barcode RNA nucleotides are in green and, the DNA 
nucleotides are in blue. 
Name Type Sequence 5'-> 3' Length nt 
v1.5 sRNA 3' Adapter 3' APP-UCGUAUGCCGUCUUCUGCUUGUidT 22 
GA_ACA_5adapter_1 5' GTTCAGAGTTCTACAGTCCGACGAUCACA 29 
GA_CAU_5adapter_2 5' GTTCAGAGTTCTACAGTCCGACGAUCCAU 29 
GA_GUA_5adapter_3 5' GTTCAGAGTTCTACAGTCCGACGAUCGUA 29 
GA_UGU_5adapter_4 5' GTTCAGAGTTCTACAGTCCGACGAUCUGU 29 
GA_AGC_5adapter_5 5' GTTCAGAGTTCTACAGTCCGACGATCAGCAU 31 
GA_AGC_5adapter_6 5' GTTCAGAGTTCTACAGTCCGACGATCCUGAU 31 
GA_AGC_5adapter_7 5' GTTCAGAGTTCTACAGTCCGACGATCGACAU 31 
GA_AGC_5adapter_8 5' GTTCAGAGTTCTACAGTCCGACGATCUCGAU 31 
 
The procedure of ligation was as follows: 5.0 µl of total RNA in nuclease-free water was mixed with 
1.0 µl of the 3'-adapter and preheated to 70°C for 2 minutes to disrupt any secondary structures and 
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dimerization. Next a master mix was prepared, for one sample: 1.0 µl 10X T4 RNA Reaction Buffer, 
0.8 µl 100 mM MgCl2, 1.5 µl T4 RNA Ligase 2 Truncated (New England BioLabs), 0.5 µl RNase 
Inhibitor. The volumes of each reagent were multiplied by the numbers of samples being prepared and 
10% extra reagent was included to cover for pipetting errors. The master mix was properly mixed by 
pipette and 3.8 µl of the mix was added to the preheated RNA and adapter mix (total volume 9.8 µl). 
The ligation mix was incubated on a preset thermal cycler (Bio-Rad C1000) at 22°C for 1 hour. The 
3'-adapter (v1.5 sRNA 3' Adapter see table 2) that was used has a modification in the 3' end which 
stops any ligation to this end and eliminates adapter dimer ligations in this step. The next step was the 
5' ligation. First the 5'-adapters were preheated to 70°C for 2 minutes. Then 1.0 µl of the 5'-adapter 
was added to the ligation mixture along with 1.0 µl 10mM ATP and 1.0 µl T4 RNA Ligase 1 (New 
England BioLabs). The ligation mixtures were properly mixed with a pipette and incubated at 20°C for 
1 hour followed by hold at 4°C. The samples were directly preceded to cDNA synthesis and PCR 
amplification. Leftovers and backup were stored at -70°C. 
cDNA synthesis and PCR amplification 
The ligation products were converted to cDNA in a reverse transcription (RT) reaction. A volume of 
4.875 µl of the 3' and 5'-adapter ligated RNA was mixed with 1.0 µl of the RT primer (see table 3) and 
heated to 70°C for 2 minutes then put on ice. A RT master mix was prepared, for one sample: 1.0 µl 
10X MulV RT reaction buffer, 0.625 µl 10 mM dNTP Mix, 1.0 µl 100 mM DTT, 0.5 µl RNase 
inhibitor, 1.0 µl MuLV Reverse Transcriptase (Applied Biosystems). The volumes of each reagent 
were multiplied by the numbers of samples being prepared and 10% extra reagent was included to 
cover for pipetting errors. The master mix was properly mixed by pipette and 4.125 µl of the mix was 
added to the preheated adapter ligated RNA and RT primer (total volume 10 µl). The mixture was put 
in a thermal cycler (Bio-Rad C1000) with the reaction conditions: 42°C for 1 hour, then 70°C for 5 
minutes for enzyme inactivation. 
The cDNA were amplified in a polymerase chain reaction (PCR). A PCR master mix was prepared, 
for one sample: 30.75 µl Nuclease-free water, 5.0 µl 10X Expand High Fidelity Buffer, 1.0 µl Primer 
GX1, 1.0 µl Primer GX2, 1.5 µl 10 mM dNTP Mix, 0.75 µl DNA Polymerase Expand High Fidelity 
PCR System (Roche). The volumes of each reagent were multiplied by the numbers of samples being 
prepared and 10% extra reagent was included to cover for pipetting errors. The master mix was 
properly mixed by pipette and 40 µl of the mix was transferred to a nuclease-free 200 µl PCR tube. 
Then 10 µl of the single stranded reverse-transcribed cDNA were added, resulting in reaction volumes 
of 50 µl. The PCR reaction were performed on a thermal cycler (Bio-Rad C1000) under the following 
cycle conditions: 98°C for 30 seconds followed by 15 cycles of; 98°C for 10 seconds, 30°C for 30 
seconds, 72°C for 15 seconds; then 72°C for 10 minutes, and hold at 4°C. The RT primer and the PCR 
reverse and forward primers, presented in table 3, were all manufactured by Illumina. The Forward 
primer has an overhang in relation to the 5'-adapter which it compliments to. This results in an 
addition in length in the PCR reaction.  
Table 3. The three primers by name, type, sequence, length in nt, and concentration used in the RT-PCR and 
PCR reactions. The reverse transcription (RT) primer and the reverse PCR primer have the same sequence i.e. 
they are identical. 
Name Type Sequence 5'-> 3' Length nt Concentration 
SAR RT  RT CAAGCAGAAGACGGCATACGA 21 Not known 
GX1 Reverse CAAGCAGAAGACGGCATACGA 21 25 µl 
GX2 Forward AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 44 25 µl 
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Gel purification of cDNA constructs 
After the PCR the DNA libraries were purified using a polyacrylamide gel electrophoresis (PAGE) 
gel. The PAGE gel used was a 6% TBE gel. The runtime was 26 min and the voltage was 180 V. 
In the process of ligation a byproduct of adapter dimers are formed (one 5'-adapter is ligated with one 
3'-adapter). The gel separation is to exclude the adapter dimers and reduce their appearance in the 
sequencing data later on. The gel purification step also allows for size separation upwards, i.e. 
enabling exclusion of longer fragments.  
In the gel purification step only those bands that matched the desired lengths are to be cut out. In the 
PCR reaction the forward primer adds 23 nt to the cDNA because of the overhang. The adapter dimer 
is approximately 74 or 76 nt (23 added from the Forward Primer GX2 + 22 from 3'-adapter + 29 or 31 
from 5'-adapter). The bands containing the 18-60 nt RNA fragments with both these adapters are a 
total of 92-94 to 134-136 nt in length. The band containing 22 nt RNA fragment with both adapters are 
96-98 nt in length. The band at 125 nt is containing 48 or 50 nt RNA fragments, i.e. fragments longer 
than miRNAs. The sequencer used, and described further down in the text, are limited to sequences 
with lengths up to approximately 2 x 100 bp. So, to use the full capacity of the sequencer one can 
choose the bands that represent sequences that are approximately 150 bp long because the adaptors 
add on some nucleotides also.  
Gel-pieces containing the constructs of the desired lengths were cut out with a sterile scalpel and put 
in a sterile nuclease-free 0.5 ml microcentrifuge tube sitting inside a 2.0 ml microcentrifuge collecting 
tube. The 0.5 ml tubes had been punctured in the bottom from the tube opening, 3-4 times with a 
sterile 21-gauge needle. The stacked tubes were centrifuged in a benchtop microcentrifuge at 14,000 
rpm (approximately 20,000 x g) for 2 minutes at room temperature. During the centrifugation the gel 
is forced through the holes and shred into smaller pieces. Shredding the gel in this fashion makes the 
gel pieces similar in size for parallel samples and the smaller pieces enhances the elution of the DNA 
constructs. The next step was to discard the upper 0.5 ml tube and add 250 µl 1X Gel Elution Buffer, 
provided by Illumina, onto the gel debris in the 2 ml tube. The DNA constructs were eluted under 
gentle rotation in a fridge (+2 to +8°C) overnight. 
The eluate and the gel debris were transferred to the top of the filter of a Spin-X cellulose acetate filter 
tube and centrifuged in a benchtop microcentrifuge at 14,000 rpm (approximately 20,000 x g) for 2 
minutes at room temperature. The filter was discarded and 1 µl of glycogen (20µg/µl) was added 
along with 25 µl of 3M NaOAc, and 975 µl of pre-chilled, -15° to -25°C absolute ethanol (99%) to 
each Spin-X tube. The glycogen and NaOAc cause the DNA to precipitate in absolute ethanol and 
cold. The tubes were put in -20°C for 1 hour then centrifuged at 14,000 rpm (approximately 20,000 x 
g) for 30 minutes at 4°C. The supernatants were discarded and the pellets were washed in 500 µl of 
room temperate 70% ethanol. Then the tubes were centrifuged at 14,000 rpm (approximately 20,000 x 
g) for 15 minutes at 4°C. The supernatants were discarded and the pellets were left intact. The samples 
were set to air-dry for 5 minutes then the pellets were resuspended in 10 µl Nuclease-free water.  
Library concentration measurement with Qubit fluorometer  
A Qubit
®
 fluorometer from Invitrogen was used to measure the concentrations of the libraries. The 
Qubit is much more accurate than using NanoDrop on low concentrations. When measuring on higher 
concentrations the techniques are equally good. This is because in the Qubit quantitation platform use 
molecule-specific fluorescent dyes to measure the concentration of the specific molecule of interest. 
The NanoDrop technique relies on UV absorbance, which cannot completely distinguish between 
DNA, RNA, degraded nucleic acids, free nucleotides, and other contaminants. With the Qubit 
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different assays can be used, with dyes targeting specific types of molecules. The dsDNA High 
sensitivity assay (assay range: 0.2-100 ng) was used to measure the concentrations of the libraries. The 
concentrations of the libraries ranged between 10-25 ng/µl. 
Sequencing  
The sequencing was done in several steps. The following text describes the denaturation, dilutions, 
clustering and, sequencing steps. 
Dilutions and sample preparations prior to cluster generation 
First the samples need to be diluted several times prior to cluster generation since only tiny amounts, 
in the range of pM, are needed. The desired final concentration to use depends on the density of 
clusters that is desired. 7 pM usually generates 425 000 clusters/mm
2
 and was the concentration that 
was chosen. The concentrations of the DNA are in molar. Therefore the concentration form the Qubit 
fluorometer, an estimate of an approximate length of the sequences, and an average weight of the 
nucleotides was used to calculate the molarity. Because the libraries have different barcodes they can 
be pooled and run together and still be distinguishable from each other. 
The five libraries were diluted first to 10 nM, then to 2 nM in volumes of 10 µl each. Thereafter 5 µl 
of each library were pooled to one sample of 25 µl containing 2 nM pooled cDNA library construct 
(the DNA template sample). The solution that was used for the dilutions was called Buffer EB 
(Elution Buffer) from Qiagen (Lot No.: 130173084). Instead of using this buffer one could use 10 mM 
Tris-Cl, pH 8.5 + 1 % Tween 20. 
The next step in the preparations was to denature the DNA template, i.e. separate double stranded 
DNA. This was done with 10 µl 0.1 M NaOH added to 10 µl of the 2 nM DNA template in a 1.5 ml 
microcentrifuge tube. The tube was mixt by vortex and spun down followed by 5 minute incubation in 
room temperature. Next all the denatured DNA (20 µl) was transferred to a 1.5 microcentrifuge tube 
containing 980 µl pre-chilled Hybridization buffer (HT1) from Illumina and was put on ice. This 
dilution created a 20 pM denatured DNA template stock. 
To obtain the final concentration of 7 pM, 350 µl of the 20 pM denatured DNA template stock was 
mixed with 650 µl pre-chilled HT1 solution. 
As a control in the cluster generation a synthetic DNA called PhiX provided by Illumina was used. 
PhiX is fragments of a bacteriophage (viral) genome and have no similar sequence in the human 
genome. The PhiX comes in a 10 nM stock and was prepared and diluted in similar manner as 
described above to a concentration of 7 pM. From this sample 10 µl 7 pM PhiX was added to the 1000 
µl denatured DNA template with the concentration 7 pM.  
Loading the DNA template on the flow cell and cluster generation 
Next from the 7 pM denatured DNA template sample 120 µl was used to load in one lane on a flow 
cell. The flow cell was placed on a cluster station from Illumina, called a cBot and clusters were 
generated. A flow cell, see figure 2, contains eight lanes/channels and each lane is built up by three 
columns. Each of the three columns, in turn, consists of 100 squares tiles. The surfaces of these tiles 
are coated with single stranded primers that are complementary to the end part of the ligated adapters 
used in the library creation. The 3' and 5' ends are different from each other but the same for all the 
sequences in the samples so the attached primers are of two types. The first step in the cluster creation 
is that the samples are loaded on the flow cell and the DNA sequences attach to the surface. As 
mentioned above, the samples were previous to this diluted, so when the sequences attach to the 
surface they are spread out over the tile areas. The surface primers are placed with fixed distances 
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from each other to allow for the attached DNA sequence to bend over and bind to an adjacent primer. 
This is what happens next, i.e. the DNA sequences bends over and bind to the primers. Unlabeled 
nucleotides are added and amplification synthesis is initiated, starting from the primer. This phase is 
referred to as solid-phase bridge amplification. When the synthesis is completed the strands are 
denatured. Now there are two sequences complementary to each other and both are attached to the tile 
area. Next several cycles of solid-phase bridge amplification are performed so that clusters containing 
huge amount of identical and complementary sequences are generated. In this fashion, all sequences in 
the samples create individual clusters separated with some distance depending upon what 
concentrations are used. As mentioned in the previous text using a concentration of 7 pM usually 
generates 425 000 clusters/mm
2
. Each cluster contains one unique sequence, and half of the sequences 
in one cluster are attached in its 3' and half are attached in its 5' end. The clustering took 
approximately 4 hours.  
 
Figure 2. Illustration of a flow call from Illumina. The flow cell in the picture is in approximately the original size. 
The flow cell has eight separate lanes. 
The sequence reaction on the HiSeq 2000 
After the clustering was completed the next step was the actual sequencing which was done on a next 
generation sequencer HiSeq 2000 from Illumina. The flow cell was placed in the sequencer and 
reagents were added. The sequencing is performed in several cycles. One cycle starts with the addition 
of reagents, including all four labeled nucleotides, a DNA polymerase and a primer. The primer that 
was used is presented in table 4. The fluorescent molecule is attached to the base and each base (A, C, 
G and T) has its unique color. All the nucleotides contain a block in the 3' end hindering more than 
one nucleotide to be incorporated at the time. The first base is incorporated and unincorporated bases 
are removed. The fluorescent signal is detected. Next the fluorescent molecule is removed from the 
base and the 3' block is removed. Then the cycle is repeated by the addition of new reagents. The run 
took approximately 48 hours.  
Table 4. The Small RNA Sequencing Primer from Illumina used in the sequencing reaction. 
Name Sequence 5'-> 3' Length nt 
Small RNA Sequencing Primer CGACAGGTTCAGAGTTCTACAGTCCGACGATC  32 
 
Data analysis 
Since the sequencing of our samples failed to produce data, all datasets analyzed were downloaded 
from the Gene Expression Omnibus (GEO) (website: http://www.ncbi.nlm.nih.gov/geo/). The GEO 
is administrated by the National Center for Biotechnology Information (NCBI) and is a database that 
was first established in year 2000. From the start the GEO database was meant to be a database 
containing all published raw data from expression analysis with microarray technology. Later on when 
sequencing techniques emerged the GEO database adapted to also include these datasets (Barrett et al. 
2011). The datasets used were fourteen altogether originating from two different publications. One 
dataset represents one library and all the libraries were prepared in similar ways as described in the 
text above. Table 5 and 6 below, summarizes the data surrounding the datasets. All fourteen libraries 
consist of sequences that are between 18-30 nt in length. 
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Table 5. The table shows a descriptive data summary of ten sequence libraries taken from Zhang et al. 2012. 
Article: Zhang et al. 2012     
GEO reference number:  GSE31299    
Individual dataset number Description Age (years) individuals in the pool lengths (nt) 
SRR332232  human serum pooled 1 (male) 26.3±1.9 11 ~18-30 
SRR332233  human serum pooled 2 (female) 24.2±1.3 10 ~18-30 
SRR332234  human serum pooled 3 50.9±7.9 10 ~18-30 
SRR332235  human serum pooled 4 50.9±7.9 10 ~18-30 
SRR332236  human serum pooled 5 50.9±7.9 10 ~18-30 
SRR332237  human serum pooled 6 50.9±7.9 10 ~18-30 
SRR332238  human serum pooled 7 50.9±7.9 10 ~18-30 
SRR332239  human serum pooled 8 50.9±7.9 10 ~18-30 
SRR332240  human serum pooled 9 50.9±7.9 10 ~18-30 
SRR332241  human serum pooled 10 50.9±7.9 10 ~18-30 
 
Table 6. The table shows a descriptive data summary of four sequence libraries taken from Vaz et al. 2010.   
Article: Vaz et al. 2010     
GEO reference number:  GSE19812    
Individual dataset number Description Age (years) individuals in the pool lengths (nt) 
SRR039190 Normal Blood cells library 1 - Not a pool ~18-30 
SRR039191 Normal Blood cells library 2 - Not a pool ~18-30 
SRR039192 K562 cancer cell line - Not a pool ~18-30 
SRR039193 HL60 cancer cell line - Not a pool ~18-30 
 
The datasets from the first publication, Zhang et al. 2012, consists of ten datasets with the GEO 
reference number GSE31299. These ten libraries all originate from pools of blood serum samples 
taken from healthy Chinese individuals. The first library consists of serum from 11 males with mean 
age 26.3±1.9 years. The second library consists of serum from 10 females with a mean age 24.2±1.3 
years. The gender distribution in the other eight libraries were not revealed in the paper and therefore 
considered as not known. These libraries each consist of serum from pools of 10 individuals. The 
mean age for all these 80 individuals was 50.9±7.9 years. 
The datasets from the second publication, Vaz et al. 2010, consists of four datasets with GEO 
reference number GSE19812. Two of the datasets are libraries created from normal white blood cells 
form two healthy Indians. The other two datasets are libraries created from two different blood cancer 
cell lines, K562 and HL60. The K562 cell line was the first human immortalized chronic myeloid 
leukemia (CML) line to be established and bear some resemblance to undifferentiated granulocytes, 
i.e. a certain category of white blood cells (Koeffler and Golde 1980). HL60 on the other hand, is a 
leukemic cell line derived from a human with acute promyelocytic leukemia. This cell line can be 
chemically stimulated to differentiate to resemble mature granulocytes (Koeffler and Golde 1980). 
Both cell lines are commonly used in blood related research experiments. 
These fourteen libraries were aligned against the human genome (version 64) provided from the 
website ENSEMBL (www.ensembl.org). The aligning programing was done by a member of our 
group and is presented in a schematic illustration in figure 3. The figure looks quite complicated but 
the programing pipeline can be described in short in a few steps. First, all the sequences were stripped 
of their adapters, filtered and identical reads were clustered together. Then these sequences were 
aligned against the haploid human genome as well as the human mitochondrial genome. Mismatch in 
the ends of the sequences were tolerated to constrained limits. This is because additions of nucleotides 
to the 3' and 5' ends of miRNAs are frequently occurring. Some sequences did not align to the human 
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genome. Each uniquely sequenced sequence was called a read. Next the aligned sequences were 
annotated, i.e. information on where in the human genome the read was mapping and what that 
sequence was known as was collected. In this annotation all the human miRNAs in miRBase were 
used. The sequences were divided on whether they did or did not annotate. Then information on 
differential expression of each sequence was registered, i.e. different additions in both the 3' and 5' 
ends of the sequences. 
 
Figure 3. The programing pipeline that was used to align the sequence data to the human genome. 
In the result an overview of the distribution of sequences in the libraries are presented in bar charts. 
The distribution of sequences in each library is also presented in pie charts. To further analyze the 
differences in the libraries some questions were formulated. These questions were the following. 
 Which are the 20 most frequent sequences that are common for all the serum libraries, 
common for the two blood cell libraries and are the most frequent sequences in the cancer 
libraries? 
 Amongst the serum libraries, is there a difference between the 20 most common sequences in 
the male library and the female library? 
 The average age of the males and females in the two libraries are young, ~25 years, compared 
to the eight other serum libraries which have an older average of ~50 years (see table 4). Is 
there a difference between the 20 most common sequences regarding age? 
In order to extract the information to answer the questions above the data that came out of the 
alignment were further processed with the statistical program R
®
. The 100 most common reads for 
each library were extracted and combined. This presented a list that contained almost 600 unique reads 
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because the 100 most common reads in the libraries were not all the same between the libraries. The 
count of each read was divided by the total amount of unique reads in each library, revealing 
frequencies instead of counts. This was done as a normalization of the data. The sums of the 
frequencies were calculated for the grouped libraries according to questions above. Then the 
frequencies were ranked by the sums. As mentioned in the introduction one specific miRNA can vary 
in length due to some variation in processing and can exist with several different additions both in the 
5' and in 3' ends. As a consequence of this, one miRNA will appear several times in the data sets after 
it has been run through the pipeline and in the list described above, each variant will be a unique read. 
Most of the non-annotated reads also occur with varying length. To take this into account the reads 
that mapped to the same chromosome and to the same small region plus minus some nucleotide, were 
collapsed and the frequencies were added together. In this way the 20 most common sequences were 
detected. In the results the comparisons are presented with Venn diagrams. 
 
Result 
 
Pre sequencing preparation and cDNA library construction 
As mentioned in the materials and methods, a test run were performed where four different 
concentrations of a spike pool were added to plasma samples. The total RNA content in the plasma 
samples was isolated and libraries were constructed following the pathway previously described. After 
the amplification the constructed libraries were run on a 6% PAGE gel. Figure 4 shows three pictures 
of this gel, taken with a UV trans-illuminator. The four samples with libraries containing different 
concentrations of the RNA spike pool were loaded in lane 2-5. Lane 6 contained one extra library not 
of concern for this project. A 25 bp ladder from illumina were loaded in lane 1 and 7. In figure 4, the 
gel to the left is the whole gel and the gel in the middle is after the short pieces, below 75 nt, were cut 
out. The gel-picture at the right is after the final cuts, after extracting gel pieces containing library 
pieces approximately between 75 and 125 nt. 
 
Figure 4. Three pictures of the same 6% PAGE gel and a ladder. The ladder is the 25 bp ladder provided by 
illumina. The ladder is the same as in the gel. The three gel-pictures illustrate where the cuts were made. The 
numbers represents the lane numbers. 
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Investigating the libraries that failed clusters generation 
In the beginning of the sequencing run on the HiSeq 2000 it shows if the clustering was successful or 
not. Unfortunately as mentioned earlier there were hardly any clusters on the flow cell in the 
experiment using four different libraries with varying concentrations of the spike pool. The few 
clusters that were there probably were the PhiX control. To investigate why no clusters was created the 
libraries were amplified in a PCR and run on a 6% PAGE gel. The library samples that were used were 
the leftovers from the 10 nM samples (se materials and methods). The primers used in the PCR were 
GX1 Reverse and GX2 Forward, from table 3, which would only give an amplification product if the 
library construct were successfully created. Figure 5 shows a 6% PAGE gel of the amplified libraries.  
 
Figure 5. 6% PAGE gel of small RNA cDNA libraries. The lanes are numbered 1-10. Lane 2 contains a 50 bp 
ladder and lane 8 a 25 bp ladder. Lane 3-7 contains 5 sample libraries which failed in a sequencing attempt. 
The amplification was successful in the sense that the bands on the gel in figure 5 are clearly visible. 
The fragments are between 75 and 100 bp. 
Data analysis 
As a consequence of the failed sequencing i.e. that the libraries described above did not generate any 
sequence data; fourteen datasets of libraries publically available were downloaded. In the materials 
and methods these fourteen datasets are described in table 5 and 6. These datasets were run through 
our programing pipeline, which compares the sequences against the human genome. The amount of 
data that came out of the run, contained detailed information on annotations and were of enormous 
sizes. Each unique sequence constitutes a read. Figure 6 presents two bar charts showing the 
distribution of the reads, for the average of the serum libraries and the average of the blood cell 
libraries. The categories in chart A (Average Serum) are: Not annotated, miRNA, Overlap annotated, 
Rest annotated and, Not aligned. The purple “Rest annotated”, represents the rest of the annotated, i.e. 
all those sequences that map and annotate to some known sequence such as snoRNAs, tRNAs, rRNAs, 
etc. The “overlap annotated” are sequences that annotate to two or more known sequences, e.g. a 
miRNA inside a coding sequence or a pseudogene. In chart B (Average Blood cells) snoRNAs are 
displayed in its own column because the high representation in these libraries. 
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Figure 6. Two bar charts describing the distribution of reads for the average of the ten serum libraries (A) and 
the average of the two blood cell libraries (B). Al the reads are 18-30 bp in length. The reads are categorized in 
five categories in the charts: dark blue “Not annotated” are reads that mapped to the genome but did not 
annotate; read “miRNA” is recognized known miRNA; green “Overlap annotated” are reads that annotate to 
several known sequences; purple “Rest annotated” is the rest of the reads that aligned and did annotate; light 
blue “Not aligned” is reads that did not align to the human genome. In the blood cells chart a sixth category, 
snoRNA, is included. This is because the snoRNAs constituted such a big part of the reads. In A the snoRNAs are 
included in the purple column (Rest annotated). The error braes represent one standard deviation.    
In figure 6 it clearly shows that the overall read distribution profile of serum and blood cells differ a 
lot. The percentage of reads constituting miRNAs (red bar in figure 6 A and B) is much higher in the 
blood cells than in the serum. The percentages of sequences that do not align to the human genome 
(light blue bars) also differ a lot between blood cells and serum.  
Another way to visualize the same data as in figure 6 is to show it in pie charts. In figure 7 the read 
distributions are displayed in pie charts for each serum library individually and the average. The 
average is the same as presented in bar chart A in figure 6. The reason to display all libraries is to 
show the diversity. The diversity is huge, for example the miRNA percentage range from 3 to 74% of 
the overall reads in the different libraries and on average 25%. Notably, the not aligned percentages of 
the reads are very high, ranging from 17 to 80% and 42% on average. The mapped but not annotated 
differs a lot also, between 6 and 62% and on average 24%.  
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Figure 7. Pie charts over the distribution of reads in ten sequence libraries of small RNAs extracted from serum. 
The light blue “Not aligned” represents the reads that did not match the human genome and varies between 
17 and 80%. The percentage of miRNAs varies between 3 to 75%. Down to the right is the average presented, 
which is the same as bar chart A in figure 6. 
In figure 8 the read distributions are displayed in pie charts for the two blood cell library along with 
the average of these two and the two cancer cell lines, K562 and HL60. The average is the same as 
presented in bar chart B in figure 6. The different distribution patterns in the two blood cell libraries 
are striking. 
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When comparing the read distribution between the libraries in both figure 7 and 8, there is a striking 
difference in what percentages the miRNAs constitutes. The read distribution in the two blood cell 
libraries differ allot from each other, pie chart A and B in figure 8. The K562 cancer library is more 
similar in the overall read distribution to the first blood cell library (compare pie chart C to A in figure 
8) whereas the HL60 cancer library more resembles the other blood cell library (compare pie chart E 
to B in figure 8). 
 
Figure 8. Pie charts over the distribution of reads in different libraries. In the two cancer cell lines the snoRNA 
are included in the purple category “Rest annotated”. In the K562 cancer library the purple category is 
relatively huge 26%. This part consists of some relatively large subgroups: ~6% rRNA pseudogene, ~5% rRNA, 
~4% tRNA, and ~4% snoRNA. 
To further analyze what kind of miRNAs and other sequences these fourteen libraries contain, the 20 
most frequent sequences in all libraries were extracted. The libraries were filtered so that only 
sequences that did map to the human genome are amongst the 20 most common sequences. This is 
important to point out, because such high percentages in some libraries are constituted by sequences 
that did not map the human genome. In figure 9 the 20 most frequent reads for the two cancer cell 
lines are compared to the two blood cell libraries together in a Venn diagram. Eleven sequences are in 
common for all; they are encircled by all three circles.  Several of the sequences are miRNAs 
belonging to the let-family. All the miRNAs have a prefix “has-” in front of the name indicating the 
human origin. All of the RNAs in the Venn diagram in figure 8 are not miRNAs. There are one 
mitochondrial tRNA pseudogene (Mt tRNA pseudogene AC073308.1-201), one rRNA pseudogene 
(rRNA pseudogene AP003035.1-201), and one snoRNA (SNORD78-201), and several NAO (not 
annotated). The NAOs are reads that did not annotate but did align to the genome (these constitute the 
dark blue bars and pie pieces in figure 6, 7 and 8). The information within the parenthesis after the 
NAO describes on which chromosome, which strand (+ or –) and between which nucleotides the 
sequence mapped. Most of the NAOs existed in several isoforms with varying length in both 3' and 5'. 
The one presented in the parenthesis are the most common variant, but represents all the isoforms. 
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Figure 9. Venn diagram comparing the 20 most common RNAs in the libraries from two different cancer cell 
lines, HL60 (green circle), K562 (purple circle) and the two human blood cell libraries together (red circle). The 
names of the RNAs are included as well as the percentage.  
Figure 10 shows a Venn diagram comparing the 20 most common sequences for all of the serum 
libraries together and the two blood libraries together. Only four out of 20 are in common (20%). The 
blood cells contain several miRNAs in the let-family, whereas the serum total does not contain as 
many of its 20 most common. The serum total 20 most common, contains among others miR-122 
which is specifically expressed in liver cells. 
 
Figure 10. Venn diagram comparing the 20 most common sequences in the ten serum libraries together (yellow 
circle) and the two human blood cell libraries together (read circle). The names of the RNAs are included as well 
as the percentage.  
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In figure 11 the serum libraries consisting of pools of males and females are compared. Eleven out of 
the 20 most common reads are the same (55%).  
 
Figure 11. Venn diagram comparing the 20 most common sequences of the serum male and female pool 
libraries. 
In figure 12 the 20 most common sequences are compared between serum from young and old. The 
young serum is the most common sequences when taking the male and female libraries together, with 
an average age approximately of 25 years, see table 5 in the materials and methods. The serum old is 
from the eight other serum pool libraries, with an average age approximately of 50 years, see table 5 in 
the materials and methods.  The gender distribution within the eight serum pools is not known. 
 
Figure 12. Venn diagram comparing the 20 most common sequences from the serum young and old libraries. 
The serum young was the most frequent of the male and the female pool libraries together (age ~25 years). 
The old is the most frequent of the eight serum pool 1 to 8 together (age ~50).  
Only four sequences are the same (20%) for both young and old. Notably one miRNAs is present 
amongst the 20 most frequent sequences in all serum and blood libraries but not in the cancer cell 
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lines, namely has-mir-185 (miR-185). Two sequences NAO (8 + 41517964-41517983) which is a not 
annotated sequence and miR-486 is amongst the 20 most common in both serum sample comparisons 
(figure 11 and 12) but does not show up amongst the 20 most common sequences in the blood cells or 
the two cancer cell line libraries (figure 9).  
Described above are results where the 20 most common RNAs in the samples are compared. Table 7 
shows the total percentage of the 20 most common RNAs for the serum libraries, the blood cells 
libraries and, cancer cell libraries. The table also presents the percentage of the 20 most common 
sequences in the serum total, serum young (male and female together), serum old (the serum pool 
libraries 3 to 10 together) and, the blood cell libraries together.  In table 7, it clearly shows that there is 
a huge variation between what percentages these, 20 most common sequences, constitute in the 
individual libraries. In the HL60 library the 20 most common sequences constitute 90% of that library 
compared to the K562 library within which only 31% of the library is represented by the 20 most 
common sequences.  
Table 7. The total percentage of the 20 most common reads in the serum libraries, the blood cell libraries and, 
the blood cancer cell line libraries described in table 5 and 6. The bar represents the percentage; a fully filled 
field is 100%. The percentage of the 20 most common reads in the serum total, serum young, serum old and, 
blood cells together are also displayed. These are the 20 most common reads that are compared in the Venn 
diagrams in figure 9, 10, 11 and, 12. 
 
Notably, in the HL60 library let-7f-1 and let-7f-2 constitute approximately 50% of all reads (data not 
shown). Further, let-7g, let-7f1-1 and let-7f-2 constitute approximately 53% of the reads in the serum 
female library but only 4% of the reads in the serum male library (data not shown).  
When comparing the 20 most common for each serum library to the total serum 20 most common, it 
shows that some libraries contribute more than others (data not shown). Only three out of the 20 most 
common miRNAs are the same for all the 10 serum libraries. This even further highlights the diversity 
between the libraries. 
Library Total percent of the 20 most common reads
Serum pool l ibrary 1 (Male) 43%
Serum pool l ibrary 2 (Female) 82%
Serum pool l ibrary 3 60%
Serum pool l ibrary 4 58%
Serum pool l ibrary 5 57%
Serum pool l ibrary 6 64%
Serum pool l ibrary 7 66%
Serum pool l ibrary 8 39%
Serum pool l ibrary 9 68%
Serum pool l ibrary 10 73%
Serum total 58%
Serum young (male and female) 61%
Serum older (pool 3 to 10) 60%
Blood cells l ibrary 1 46%
Blood cells l ibrary 2 77%
Blood cell libraries together 66%
K562 31%
HL60 90%
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Discussion 
 
When investigating components in body fluids like serum and plasma one could expect a huge 
diversity because of the heterogeneity of these fluids. It is well-known that the blood composition 
varies a lot due to all imaginable conditions such as diets, drugs, fitness, stress, age, and time of 
collection during the day. So when investigating miRNAs circulating in the blood one should expect 
these molecules to occur in similar fashion as other molecules. Despite of this, there are several 
biomarkers used as indicators of different conditions and diseases. 
As described in the materials and methods, RNA spikes were added early on in the creation of libraries 
as controls. These spikes were intended to be used to normalize the different libraries to each other and 
thereby get more reliable comparisons between the libraries. The clustering failed and no sequence 
data were obtained from our libraries with spikes. The fourteen libraries that make up the results did 
not contain any spikes. In the process of extracting the 20 most common sequences, the count of each 
read were divided by the total number of reads in that library to display frequencies. If one would have 
used spikes instead, then one would have subtracted or added the value of the some of the spikes to 
each reads count before calculating the frequencies. This would have presented frequencies that would 
have been much better to compare. Since the spikes were added in the same concentrations to all 
samples and all the samples were handled equivalent, the spikes would tell if there had been any 
unexpected material losses and the spikes could be used to compensate for this. However, the 20 most 
common sequences in the fourteen different libraries can still be compared in the way displayed in the 
result. 
When constructing cDNA libraries aimed for sequencing one could do this with several different 
approaches. We chose an approach where we used one 3'-adapter, the same for all, and different 5'-
adapters with unique barcodes for each library. Another approach is to have the barcode in the 3'-
adapter. Yet another design could be to incorporate the barcode in one of the PCR-primers, and then 
the 3'-adapter and 5'-adapter used is the same for all libraries. The last approach is commercially 
available in a kit from Illumina. The reason for choosing the design with 5'-barcodes was that our 
group did already have eight 5'-adapters with unique barcodes and to order more of these would be the 
most economical option. The choice of approach is more of a technical and economic nature and 
would not affect the quality of the cDNA libraries. 
In the materials and methods it is described how libraries were constructed and how, in the end, the 
clustering failed and no sequence data were created. In an attempted to investigate why it failed the 
libraries from that experiment was amplified and run on a gel, see figure 5. This amplification was 
designed so that it would only amplify sequences that contained both ligated adapters, because of the 
primers used. As shown on the gel in figure 5, there are clearly visible amplification products in all 
libraries. So why did the clustering fail? One could speculate in that perhaps were the concentrations 
measured on the Qubit lower in reality, which would give a lower concentration in all next coming 
steps and perhaps leading to a too low concentration on the flow cell and the clustering station. The 
amplification control performed would not reveal if this was the case. To control for this one could re 
do the concentration measurement on the Qubit fluorometer. To further investigate one could run a 
qPCR on the samples with primers designed so that one primer overlaps one of the ligation sites, while 
the other primer is specific for a target sequence (some of the expected miRNAs). This would give 
more specific information on if a target miRNA exist in the sample and if it is correctly constructed. In 
a qPCR like this one could also estimate the amount of adapter dimers by using primers designed so 
that one primer overlap the ligation of two adapters (one 3' and one 5' adapter) and the other primer 
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binding further away from this site. When examining the gel in figure 5 more closely it seems like 
much of the amplified product are of the size 75 bp which is the size of the predicted adapter dimer. 
All fourteen datasets presented in table 5 and 6 are approximately 18-30 nt long. This is much shorter 
than intended for our libraries and these short reads cover mostly miRNA. The reason for including 
longer, i.e. up to 120 nt, was to reveal and map other small RNAs, such as tRNAs and snoRNAs. 
Moreover, this would reveal if molecules such as pre-miRNAs (~70 nt) do exist in the plasma 
samples. These molecules would not be expected because they have been shown to be less stable in 
circulation outside the cells compared to mature miRNAs. On the other hand, if huge parts of the 
circulating RNAs originate from erupted and lysed cells in material from cancer patients, one could 
expect to find these molecules circulating anyhow. 
The high percentage of snoRNAs in the blood cell libraries, the orange category in figure 6 and 8, 
could be explained with the fact that the snoRNAs are involved in the RNA splicing machinery and 
blood cells have a high mRNA turnover. 
The mapped but not annotated sequences, the dark blue in figure 6, 7 and 8, represent sequences that 
might just be novel miRNA or other small RNAs that have not yet been described. The overlap 
annotations in figure 6 represent sequences that annotate to several known sequences in the genome. 
Many of these are probably miRNAs that sits in coding regions of genes or pseudo genes. With these 
two observations the actual percentage that represents miRNAs should be somewhat higher. 
It is interesting that the not aligned reads, the light blue in figure 6 and 7, are such a high percentage of 
the overall reads in the serum samples. One reason could be that the parameters chosen for our 
alignment. For instance reads mapping to several locations in the genome would be discarded since 
their origin is uncertain. If the parameters chosen for the alignment in the pipeline cause some 
sequences to be classified as not aligned even though they do align this could be expected to be 
equally common between libraries and could not explain the huge difference between the different 
libraries.  Also, unexpected biological events, such as RNA editing, would change the sequence on the 
RNA molecule after transcription, producing mismatches that would affect the alignment. The same is 
true for short pieces from mRNAs expanding over exon boundaries. When investigating tRNAs, 
which contains a lot of nucleotide substitutions, with sequencing techniques lots of different variants 
of the sequences are produced due to these modified nucleotides.  
When looking into biological samples, such as blood plasma and serum, one would expect the 
majority of the molecules to originate from the host itself. The samples originate from the paper were 
the authors find miRNAs from the plant world in these samples. One could speculate that the origin of 
these small RNAs could also be from bacteria in the gastrointestinal tract, from viruses, or from other 
food sources, besides from the plant world. The obvious next step to take would be to run a BLAST 
search on these sequences against all known genomes to answer what these sequences originate from. 
Yet another explanation, to the high levels of not aligned reads in the serum libraries compared to the 
levels of human miRNAs could be that the libraries are pools. If the individuals within the pools have 
eaten different diets and thereby have different sets of foreign miRNAs these miRNAs would take up a 
larger part of the libraries compared to the human miRNAs. With this argument one assumes that the 
human miRNA profiles are relatively similar and limited to the approximately 1,500 human miRNAs 
known to date. One could expect some variation in which of these human miRNAs that are present 
among the individuals in a pool, but the total amount of unique human miRNAs would be expected to 
be fewer in total than the foreign miRNAs that have a higher potential to vary because they have all 
kinds of food intake as potential origin.  
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Only one miRNA, miR-185, is amongst the 20 most common for all serum sample comparisons and 
the blood cells (figure 10, 11 and 12) but not in the cancer cell lines (figure 9). This miR-185 has 
during the past year been shown to down regulate a well-known oncogene called c-Myc which codes 
for a transcription factor that is known to be constitutively expressed in various cancers (Liao and Lu 
2011). In addition to these findings, miR-185 has been shown to target and down regulate DNA 
methyltransferases 1 which regulate global gene expression through methylations at promoter regions 
at several important genes that, in turn, codes for regulatory proteins (Zhang et al. 2011). With these 
findings, it is not surprising that miR-185 does not show up amongst the 20 most common sequences 
in the two cancer cell libraries. 
As pointed out in the results, both the not annotated sequence NAO (8 + 41517964-41517983) and 
miR-486 are amongst the 20 most common in both serum samples comparisons (figure 11 and 12) but 
is not amongst the 20 most common sequences in the blood cells or the two cancer cell line libraries 
(figure 9 and 10). The NAO (8 + 41517964-41517983) sequence is complementary to miR-486 but is 
situated on the other strand of the genome and is consequently not the star (*) sequence but the 
antisense to miR-486. There are 4 different variants of this sequence in the 100 most common 
sequences and these vary in length between 19-22 nt. It is highly probable that this sequence will be 
identified as a miRNA in the future. In a recent paper miR-486 was proposed as a tumor suppressor in 
gastric cancer (Oh et al. 2011). In the paper it was shown that miR-486 was significantly down 
regulated in gastric cancer and that 25 to 30% out of 106 studied gastric cancers had genomic loss of 
miR-486. Further, they showed that restoring miR-486 caused suppression of several pro-oncogenic 
traits in gastric cancer cells, while inhibiting miR-486 in other cells enhanced proliferation. Moreover, 
the mRNA of an antiapoptotic endogenous glycoprotein OLFM4 was proposed as the target of miR-
486 with bioinformatic and experimental support (Oh et al. 2011). If miR-486 is indeed a tumor 
suppressor miRNA, this can explain tis abstains in the cancer cell line libraries but not it’s abstains in 
the blood cell libraries. Perhaps the miR-486 is not normally expressed in high levels in blood cells, 
but then one could speculate that the two cancer cell lines, which are derived from blood cells, would 
be expected to also express miR-486 in low levels.   
As indicated in the result, on commenting upon the results presented in table 7, looking at the 20 most 
common sequences has its advantages and disadvantages. In some libraries the 20 most common 
sequences constitute as much as 90 % of the reads and in some libraries only a few miRNAs constitute 
as much as 50 % of the sequences. In general the 20 most common sequences represent approximately 
50% or more of the total reads in each library. Moreover, as mentioned in the last part of the results, 
when comparing the 20 most common for each serum library to the total serum 20 most common, only 
three out of the 20 most common miRNAs are the same for all the 10 serum libraries. This even 
further highlights the diversity between the libraries. 
There are definitely differences amongst the most common sequences in the serum libraries compared 
to the blood cell libraries as presented in figure 10 in the results. Only 4 out of 20 sequences are the 
same (20%). Moreover, when locking at what percentage these, the 20 most common sequences, 
constitutes of the overall reads in there libraries (see table 7) the serum total 20 most common 
sequences constitutes 58% and the blood cells together 20 most common sequences constitutes 66%. 
This shows that more than half of the reads are represented by the 20 most common sequences. These 
results are in line with the notion that most circulating miRNAs are not reflecting the miRNAs in 
blood cells but can have other origins. As previously mentioned in the introduction, recently the 
majority of circulating miRNAs have been shown to be associated with the Ago2 protein in the blood 
(Arroyo et al. 2011). Still others have shown a much higher correlation between the miRNA profiles 
in blood cells and in circulation (Pritchard et al. 2012), as also mentioned in the introduction. 
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Furthermore, also as mentioned in the introduction, a research group recently reported the findings that 
the miRNA population in blood cells has been shown to change in relation to various diseases that are 
not necessarily blood-borne diseases (Keller et al. 2011). The underlining cause of this change is not 
known but it could be as a response to changes in the environment caused by the disease, the authors 
of these findings argue. These findings indicate that several circulating miRNAs might originate from 
blood cells and or other cells and not from the tumors. This makes the finding of new cancer 
biomarkers more complex. But one could argue that if the miRNA profile of blood cells changes along 
with the profile of circulating miRNAs in a cancer patient the miRNAs could still be considered as 
valid biomarkers for the cancer even though the miRNAs do not originate from the actual cancer cells. 
Finally, I believe interesting times are ahead, when it comes to miRNA research. Surely new findings 
regarding miRNAs acting as key regulators in cellular processes involved in various diseases 
especially different types of cancers are to be expected in a near future. All the technologies needed 
like next generation sequencing capable of sequencing entire genomes in a few days combined with 
powerful computers capable of processing massive amount of data, are now in place. What are needed 
now are skilled and clever scientists that ask and find the answers to the right questions. Technological 
breakthroughs like next generation sequencing and bioinformatics will push the knowledge of 
molecular genetics and cellular biology into new depths. 
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